Skip to main content
Top

12-11-2019 | ANCA-associated vasculitis | Video | Article

Researcher comment: The RITAZAREM trial

print
PRINT
insite
SEARCH

Rona Smith talks about the findings from the RITAZAREM trial, showing that maintenance therapy with rituximab reduces relapse rates compared with azathioprine among patients with ANCA-associated vasculitis (2:09).

Transcript

Back to the ACR/ARP 2019 conference hub

print
PRINT